Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy (Q34645011)

3 August 2017

1 reference

title

Reducing global risk for cardiovascular disease: using lifestyle changes and pharmacotherapy (English)

1 reference

3 August 2017

0 references

cardiovascular disease

1 reference

5

Roger S Blumenthal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

Cheryl Dennison Himmelfarb

15 May 2020

3

object named as

Cheryl Dennison

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

15 May 2020

author name string

Alan Cheng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

15 May 2020

Joel B Braunstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

15 May 2020

Caitlin Nass

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

15 May 2020

publication date

1 May 2002

1 reference

3 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

15 May 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

15 May 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

15 May 2020

page(s)

205-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

The Framingham Study: ITS 50-year legacy and future promise

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Predictors of smoking cessation after coronary artery bypass graft surgery. Results of a randomized trial with 5-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

An overview of randomized trials of rehabilitation with exercise after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Exercise as cardiovascular therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Effects of walking on coronary heart disease in elderly men: the Honolulu Heart Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Aspirin therapy in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Is worrying bad for your heart? A prospective study of worry and coronary heart disease in the Normative Aging Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

21 January 2018

1 reference

12 December 2020

Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies

1 reference

12 December 2020

The effect of folic acid fortification on plasma folate and total homocysteine concentrations

1 reference

12 December 2020

Guidelines for healthy weight

1 reference

12 December 2020

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

12 December 2020

A Prospective Study of Walking as Compared with Vigorous Exercise in the Prevention of Coronary Heart Disease in Women

1 reference

12 December 2020

Physical inactivity as a risk factor for cardiovascular disease

1 reference

12 December 2020

Hemodynamic shear stress and its role in atherosclerosis

1 reference

12 December 2020

AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association

1 reference

12 December 2020

The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

12 December 2020

Homocyst(e)ine and cardiovascular disease

1 reference

12 December 2020

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group

1 reference

12 December 2020

Hypertension and diabetes: new therapeutic options

1 reference

12 December 2020

Determination of who may derive most benefit from aspirin in primary prevention: subgroup results from a randomised controlled trial

1 reference

12 December 2020

Primary prevention of coronary heart disease in women through diet and lifestyle

1 reference

12 December 2020

Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?

1 reference

12 December 2020

Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators

1 reference

12 December 2020

Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity

1 reference

12 December 2020

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

12 December 2020

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

12 December 2020

Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)

1 reference

12 December 2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment

1 reference

12 December 2020

Physical activity and 10.5 year mortality in the Multiple Risk Factor Intervention Trial (MRFIT)

1 reference

12 December 2020

Is hyperglycemia associated with cardiovascular disease? The Framingham Study

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

1 reference

12 December 2020

Beneficial Six-Year Outcome of Smoking Cessation in Older Men and Women with Coronary Artery Disease

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials

1 reference

12 December 2020

Cardiovascular complications of outpatient cardiac rehabilitation programs

1 reference

12 December 2020

The risk of myocardial infarction after quitting smoking in men under 55 years of age.

1 reference

12 December 2020

Diabetes and cardiovascular disease. The Framingham study

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

12 December 2020

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering

1 reference

12 December 2020

Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery

1 reference

12 December 2020

Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a)

1 reference

12 December 2020

Recurrence of angina after coronary artery bypass surgery: predictors and prognosis (CASS Registry). Coronary Artery Surgery Study

1 reference

12 December 2020

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

12 December 2020

Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study

1 reference

12 December 2020

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Greater case-fatality after myocardial infarction among Mexican Americans and women than among non-Hispanic whites and men. The Corpus Christi Heart Project

1 reference

12 December 2020

Coronary risk in a British Punjabi population: comparative profile of non-biochemical factors.

1 reference

12 December 2020

Smoking cessation and time course of decreased risks of coronary heart disease in middle-aged women

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

1 reference

12 December 2020

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

12 December 2020

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

12 December 2020

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

1 reference

12 December 2020

Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians

1 reference

12 December 2020

Frequency of family history of acute myocardial infarction in patients with acute myocardial infarction. Argentine FRICAS (Factores de Riesgo Coronario en America del Sur) Investigators.

1 reference

12 December 2020

How to implement physical activity in primary and secondary prevention. A statement for healthcare-professionals from the Task Force on Risk-reduction, American Heart Association

1 reference

12 December 2020

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

1 reference

12 December 2020

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

1 reference

12 December 2020

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

12 December 2020

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

12 December 2020

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

12 December 2020

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

1 reference

12 December 2020

The cardiovascular dysmetabolic syndrome.

1 reference

12 December 2020

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

12 December 2020

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

1 reference

12 December 2020

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

12 December 2020

Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4950250503

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CLC.4950250503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6653857&resulttype=core&format=json

15 May 2020

12018878

1 reference